COMBATING FLAVIVIRAL INFECTIONS WITH NOVEL BROAD-SPECTRUM MACROCYCLIC THERAPEUTIC AND PROPHLACTIC AGENTS

$1,207,935FY2020Defense Health AgencyDOD

Cyclenium Pharma Inc.

Investigators